Thermo Fisher Scientific expands global footprint for drug product development and commercial manufacturing

▴ Thermo Fisher Scientific expands global footprint for drug product development and commercial manufacturing
The investments will add 15 development and cGMP commercial production lines, leveraging Thermo Fisher's robust quality standards

Thermo Fisher Scientific, the world leader in serving science, announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines.

"We have continued to invest strategically in capacity, technology and expertise across our global network so we can accelerate innovation and enhance productivity for our customers," said Mike Shafer, senior vice president and president, pharma services, Thermo Fisher Scientific. "This has enabled us to respond quickly and support our customers with unprecedented scale and depth of capabilities to meet the high demand for new therapies and vaccines. By simplifying the supply chain and solving complex manufacturing challenges, we shorten development timelines in order to get high-quality medicines to patients, faster."

Among the Thermo Fisher sites currently being expanded are Greenville, NC.; Swindon, U.K.; and Ferentino and Monza, Italy. These investments will add 15 development and cGMP commercial production lines, leveraging Thermo Fisher's robust quality standards as well as supporting a range of capabilities including live virus, aseptic liquid and lyophilized vial filling. These projects are expected to be completed over the next two years and will create approximately 1,000 jobs.

In addition to expansions in North America and Europe, the company recently announced significant projects in Asia-Pacific, including a new sterile manufacturing facility in Singapore and a new integrated biologics and sterile drug development and manufacturing site in Hangzhou, China.

"With these investments, we've nearly doubled our global footprint for drug development and commercial manufacturing, which allows us to support our customers with unmatched flexibility, expertise and scale at a time of unprecedented demand," added Shafer.

The activities underscore the rapidly growing global demand for injectable sterile drugs, which comprise 46% of the total dosage forms securing U.S. FDA approval in 2019.

Tags : #ThermoFisherScientific #LatestNewsonThermoFisherScientific10thDec #LatestPharmaNews10thDec #NorthAmerica #Europe #USFDA

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Health-tech startup Healthkart raises Rs 536.52 Crore led by TemasekNovember 28, 2022
TummyFriendly Foods – Harmless Bio-available nutrition for little onesNovember 28, 2022
Causes, Symptoms, and Solutions to Lung Cancer November 28, 2022
5 reasons behind premature hair grayingNovember 26, 2022
Connect2MyDoctor’s cARe - Augmented Reality tool playing a crucial role in patient educationNovember 26, 2022
Bollywood Actor Kajal Aggarwal invests in D2c Startup TACNovember 26, 2022
Causes, Symptoms, Treatment, and Preventive Solutions for Ovarian Cancer November 26, 2022
Men’s health firm Bonatra raises Rs 5.5 Cr in the pre-seed funding roundNovember 25, 2022
Why is Samantha Ruth Prabhu hospitalized again in Hyderabad?November 25, 2022
RedBrick AI, a Healthtech startup, raises $4.6 million in funding from Sequoia India, Surge.November 25, 2022
Now schedule your health check-ups at a much-discounted price with MediWheelNovember 24, 2022
Kamal Haasan gets admitted to Chennai Hospital Today November 24, 2022
India's first Global Women's Health Innovation Conference to highlight the potential of Femtech & Digital InnovationsNovember 24, 2022
Pred Health - HealthTech Startup dedicated to provide Integrated care management for cancer patientsNovember 24, 2022
7 Protein Foods For Gym-Goers November 23, 2022
7 Protein Foods For Gym-Goers November 23, 2022
7 Things to know before you try Keto Diet November 23, 2022
Causes, Symptoms, and Diagnosis of Lung CancerNovember 23, 2022
MBDH Wellness focuses on improving people's lives by offering high quality careNovember 23, 2022
Ayurveda startup NirogStreet raises INR 100 CroresNovember 22, 2022